Infrastructure

The inspection took place from July 17, 2024, to July 26, 2024

The API manufacturing facility received the GMP certification from the Competent Authority of Germany

The total investment incurred for setting up the new R&D is Rs 250 crore

The capability centre aims to accelerate Pfizer’s growth across the 140 countries (ex-US) where it is present, powered by data,…

The Neovantage Innovation Parks portfolio is set up as a joint venture (JV) between Ivanhoé Cambridge, the real estate group of…

Earlier, on July 18, the facility received an OAI status

The site, known as Amgen India, aims to accelerate digital capabilities across the global organisation to further advance Amgen’s…

Rusan Pharma plans to expand its portfolio with additional APIs, including Apomorphine, Buprenorphine, Naloxone, Naltrexone,…

The Inspection was classified as Voluntary Action Indicated (VAI)

Dr Ashok Omray, Pharma Consultant, points out that despite significant advancements, the Indian pharma industry grapples with…

The facility aims to offer, process development and clinical scale manufacturing capabilities  Aurigene Pharmaceutical…

Bionova Scientific aims to offer pDNA development services and production of research grade and high quality pDNA Bionova…

Achieving the certification requires a building to reach at least 40 per cent in energy saving signifying that a building is…

Srivardhan Khemka, Director, Sanjivani Parenteral explains that pharma industry in India is undergoing a transformative shift…